# The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

> **NCT02214680** · PHASE2 · UNKNOWN · sponsor: **Carmel Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Combigan (Combination of Brimonidine and Timolol)
- **DRUG:** Timolol

## Key facts

- **NCT ID:** NCT02214680
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02214680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02214680, "The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02214680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*